FDA Inspection 800384 — GSK LLC (GlaxoSmithKline)
The FDA completed an inspection of GSK LLC (GlaxoSmithKline) on Sep 19, 2012 in Collegeville, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 19, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Collegeville, PA (United States)
Additional details
Risk Evaluation and Mitigation Strategies (REMS)